Analytical Data
-
基因名
SLC7A6OS
- Application
-
别名
2010007L18Rik; 2400002F02Rik; ADAMS proteinase-related protein; FLJ13291; MGC60796; Protein SLC7A6OS; S7A6O_HUMAN; SLC7A6OS; Solute carrier family 7 member 6 opposite strand; Solute carrier family 7 member 6 opposite strand transcript
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96CW6
-
表达区间
1-309 aa
-
氨基酸序列
MERTAVLR VKRKRSAEPA EALVLACKRL RSDAVESQ KTSEGLER ENNVFHLVAT VCSQEEPVQP LLREVLRPSR DSQQRVRRNL RASAREVRQE GRYRVLSSRR SLGTTSSGQE SEYTPGNPEA AGNSGFQLLD LVHEEGEPEA ASAGSCKTSD PDVILCNSVE LIRERLTVSE DGPGVRRQEE QKHDDYVYDI YYLETATPGW IENILSVQPY SQEWELVNDD QEPEDIYDDE DDENSENNWR NEYPEEESSD GDEDSRGSAD YNSLSEEERG SSRQRMWSKY PLDVQKEFGY DSPHDLDSD
-
分子量
35.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC7A6OS, a long non-coding RNA (lncRNA), has gained attention in recent years due to its involvement in various biological processes and potential implications in human diseases. Initially discovered through genomic studies, SLC7A6OS is located on chromosome 4 and is believed to play a regulatory role in gene expression, particularly in the context of cellular stress responses and cancer progression. Emerging evidence suggests that SLC7A6OS interacts with different proteins and microRNAs, influencing pathways related to cell proliferation, apoptosis, and metastasis. Given its significant role in post-transcriptional regulation, researchers are increasingly interested in understanding the functional mechanisms of SLC7A6OS. The recombinant protein studies of SLC7A6OS aim to delineate its structural properties and interactions, offering insights into its regulatory functions at the molecular level. Such research may contribute to the development of novel therapeutic approaches targeting SLC7A6OS in various diseases, including cancers and neurodegenerative disorders. Furthermore, understanding the role of SLC7A6OS in the cellular context and its potential as a biomarker could pave the way for innovative strategies in precision medicine. Overall, the exploration of SLC7A6OS as a recombinant protein holds promise for advancing our knowledge of lncRNAs and their significance in human health and disease.
